Company
Galimedix
Galimedix Therapeutics
- Business model
- B2B
Record updated 28 September 2026
About
Next Generation Therapies forNeurodegenerativeDiseases Mission At Galimedix, we are working to improve the lives of millions of patients worldwide by developing game-changing drugs to treat major neurodegenerative diseases where amyloid beta plays a role and where better treatments are urgently needed, including dry age-related macular degeneration (AMD), glaucoma and Alzheimer’s disease, our initial areas of focus. […]